VMVenance P. Maro

Venance P. Maro

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Venance P. Maro has a total of 79 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    The Host Transcriptional Response to Real-world Cryptococcosis in the Setting of Advanced HIV Disease Defines Dysregulated Immune Responses That Underlie Increased Vulnerability to Infection

    by Beatrice Z Sim, Julie M Steinbrink, Cameron Miller, Alejandro Antonia, J Andrew Alspaugh, Deng B Madut, Manuela Carugati, John A Crump, Blandina T Mmbaga, James S Ngocho, et al.

    Background: Cryptococcus causes life-threatening infections; however, immune programs driving the pathogenesis of these infections in the human host remain incompletely described. We leveraged whole-blood transcriptomic analysis to define distinct, conserved elements of the host immune response in participants with cryptococcal infections. Methods: RNA sequencing was performed on whole blood from adult febrile inpatients admitted to 2 hospitals in Moshi, Tanzania, to compare gene expression between participants with cryptococcal, bacterial, or viral diseases, and adult community controls. Differential expression and gene set enrichment analyses were used to characterize expression differences between pathogen-class groups. Penalized logistic regression was used to identify gene expression signatures capable of identifying Cryptococcus disease. Results: Out of 118 participants, 13 (11%) had cryptococcal disease, and 41 (34.7%) were persons with HIV (PWH). Genes upregulated in response to cryptococcosis compared to nonacutely infected community controls reflected complement activation, neutrophil activation, type I interferon signaling, and myeloid dendritic cell differentiation. When compared to combined bacterial or viral illnesses, cryptococcal disease demonstrated hyperactivation of both innate and humoral immune pathways. A series of classifiers were developed that distinguished between cryptococcal and combined bacterial or viral diseases with an AUC of 0.946. Conclusions: Overall, the host response to cryptococcosis in individuals with advanced HIV, as manifested in transcriptional profiles, informs our understanding of the pathophysiology of and susceptibility to cryptococcal infection and may support the development of novel diagnostic and therapeutic approaches.

  • Open Access

    Respiratory Pathogen Detection Among Febrile Inpatients in Northern Tanzania, 2016–2019

    by Martin Linster, Marina Zahari, Yan Zhuang, Marcus G Mah, Manuela Carugati, Ganga Moorthy, Deng B Madut, Michael J Maze, Bingileki Lwezaula, Annette Marandu, et al.

    Background: Febrile illness is a common reason for hospital admission in sub-Saharan Africa, yet the illness etiology often remains unknown. To address these knowledge gaps, we conducted respiratory pathogen testing in a cohort of febrile inpatients in northern Tanzania. Methods: We enrolled a prospective cohort of febrile pediatric and adult inpatients within 24 hours after admission to 2 hospitals in northern Tanzania. Nasopharyngeal/oropharyngeal specimens were collected for detection of 19 pathogens with polymerase chain reaction. Participants were stratified by age (<10 or and ≥10 years) and categorized into the following 3 groups: severe acute respiratory infection (SARI), non-SARI respiratory illness, or no respiratory illness. Results: Among the 1132 participants enrolled, 930 (82.1%) had nasopharyngeal/oropharyngeal specimens tested. Their median (interquartile range) age was 22.3 (2.1–44.0) years, 432 (46.5%) were female, and 378 (40.7%) had SARIs. We observed 410 pathogen detections in 359 participants (38.6%), in 256 (67.2%) of 381 in the <10-year age group and 103 (18.8%) of 549 in the older group (≥10 years old). Of the 301 pathogen detections among participants <10 years old, the most common were rhinovirus (RV)/enterovirus (EV) (n = 80 [26.6%]), influenza (n = 60 [19.9%]) and adenovirus (n = 45 [15.0%]). Of the 109 pathogen detections in participants ≥10 years old, the most common were RV/EV (n = 41 [37.6%]), influenza (n = 37 [33.9%]), and respiratory syncytial virus (RSV) (n = 6 [5.5%]). Among SARIs, the most common pathogens were influenza (n = 71 [18.8%]), RV/EV (n = 66 [17.5%]), and RSV (n = 37 [9.8%]). Conclusions: RV/EV, influenza and RSV were commonly detected among febrile inpatients in Tanzania, including in participants with SARIs. These findings have implications for vaccine development and implementation in low- and middle-income countries.

  • Antibodies to Tick Salivary Antigens AV422 and Calreticulin in Patients With Spotted Fever Group Rickettsioses and Other Febrile Illnesses in Northern Tanzania

    by Ganga S Moorthy, Bessie H Blocher, Deng B Madut, Halie K Miller, Jamie L Perniciaro, Jo E B Halliday, Blandina T Mmbaga, Bingileki F Lwezaula, Sarah Cleaveland, Venance P Maro, et al.

    Background: Timely and accurate diagnosis of spotted fever rickettsioses (SFR) is difficult due to nonspecific symptoms and testing challenges. We evaluated serum antibodies to the tick salivary proteins AV422 and calreticulin as potential markers of recent tick exposure in febrile patients from northern Tanzania. Methods: We recruited febrile patients at 2 hospitals in Moshi, Tanzania, from February 2012 through May 2014. Acute and convalescent sera from enrolled participants were tested against Rickettsia africae antigen using indirect immunofluorescence assays (IFAs). Participants with ≥4-fold rise in R africae IFA immunoglobulin G reciprocal titer between sera were classified as cases (n = 70), those with paired sera with reciprocal titer ≥64 but no ≥4-fold rise as exposed (n = 40), and participants with reciprocal titer <32 in either sera as unexposed (n = 38). Acute and convalescent sera were tested for calreticulin and AV422 antibodies using enzyme-linked immunosorbent assay. Results: We found significantly higher calreticulin antibody levels in acute sera of cases compared to exposed, unexposed, and the combined comparator of exposed and unexposed (adjusted mean difference [95% confidence interval {CI}], 17.49 [6.37–28.61]; 17.61 [6.55–28.67]; and 18.11 [9.13–27.10], respectively). Calreticulin distinguished cases from exposed and unexposed among persons 0–15 years old with positive predictive value of 0.77 (95% CI, .61–.88) and sensitivity of 0.94 (95% CI, .81–.99). Conclusions: In the acute phase of febrile illness, measurement of calreticulin antibody, a proposed marker for tick exposure, was higher in patients with confirmed tick-borne illness and had reasonable diagnostic test characteristics.


  • Open Access

    Sepsis in Northern Tanzania: A Prospective Observational Study of Clinical Characteristics, Management, and Outcomes for Adolescents and Adults With Sepsis

    by John P Bonnewell, John A Crump, Joseph R Egger, Francis M Sakita, Julian T Hertz, Kajiru G Kilonzo, Venance P Maro, Matthew P Rubach

    Background: Despite a high burden of sepsis in Sub-Saharan Africa, clinical data for adolescent and adult sepsis in this setting are limited. We sought to describe clinical characteristics, management, and outcomes in adolescents and adults with sepsis in northern Tanzania. We also assessed for clinical associations with in-hospital mortality. Methods: We conducted a prospective observational cohort study at Kilimanjaro Christian Medical Centre in Moshi, Tanzania, 2019–2020. Data were collected on demographics, clinical characteristics, and management primarily from hours 0–6 after arrival at the emergency department. We calculated bivariable risk ratios (RRs) for associations between demographic and clinical factors and in-hospital death. A multivariable-adjusted analysis was performed for associations between antimicrobial and intravenous fluid administration and in-hospital death. Results: Of 86 participants with sepsis, 25 (29.1%) died in the hospital. Baseline characteristics associated with in-hospital mortality included inability to drink unassisted (RR, 3.15; 95% CI, 1.58–6.30), altered mentation (RR, 3.94; 95% CI, 2.12–7.33), quick Sequential Organ Failure Assessment (qSOFA) score ≥2 (RR, 2.86; 95% CI, 1.42–5.72), and Universal Vital Assessment score ≥5 (RR, 6.33; 95% CI, 2.36–17.02). Twenty-nine (33.7%) received an antimicrobial by hour 6. HIV antibody testing was performed for 4 (4.7%) participants by hour 6. On multivariable analysis, neither antimicrobial administration nor intravenous fluids >1L by hour 6 was associated with in-hospital mortality. Conclusions: Sepsis at our center in northern Tanzania carried a high risk of in-hospital mortality. Further research is needed to establish the highest-yield interventions suited to the unique characteristics of sepsis in Sub-Saharan Africa.

  • Open Access

    Prevalence and risk factors for Q fever, spotted fever group rickettsioses, and typhus group rickettsioses in a pastoralist community of northern Tanzania, 2016–2017

    by Ganga S. Moorthy, Matthew P. Rubach, Michael J. Maze, Regina P. Refuerzo, Gabriel M. Shirima, AbdulHamid S. Lukambagire, Rebecca F. Bodenham, Shama Cash‐Goldwasser, Kate M. Thomas, Philoteus Sakasaka, et al.

    Background: In northern Tanzania, Q fever, spotted fever group (SFG) rickettsioses, and typhus group (TG) rickettsioses are common causes of febrile illness. We sought to describe the prevalence and risk factors for these zoonoses in a pastoralist community.Methods: Febrile patients ≥2 years old presenting to Endulen Hospital in the Ngorongoro Conservation Area were enrolled from August 2016 through October 2017. Acute and convalescent blood samples were collected, and a questionnaire was administered. Sera were tested by immunofluorescent antibody (IFA) IgG assays using Coxiella burnetii (Phase II), Rickettsia africae, and Rickettsia typhi antigens. Serologic evidence of exposure was defined by an IFA titre ≥1:64; probable cases by an acute IFA titre ≥1:128; and confirmed cases by a ≥4‐fold rise in titre between samples. Risk factors for exposure and acute case status were evaluated.Results: Of 228 participants, 99 (43.4%) were male and the median (interquartile range) age was 27 (16–41) years. Among these, 117 (51.3%) had C. burnetii exposure, 74 (32.5%) had probable Q fever, 176 (77.2%) had SFG Rickettsia exposure, 134 (58.8%) had probable SFG rickettsioses, 11 (4.8%) had TG Rickettsia exposure, and 4 (1.8%) had probable TG rickettsioses. Of 146 participants with paired sera, 1 (0.5%) had confirmed Q fever, 8 (5.5%) had confirmed SFG rickettsioses, and none had confirmed TG rickettsioses. Livestock slaughter was associated with acute Q fever (adjusted odds ratio [OR] 2.54, 95% confidence interval [CI] 1.38–4.76) and sheep slaughter with SFG rickettsioses case (OR 4.63, 95% CI 1.08–23.50).Discussion: Acute Q fever and SFG rickettsioses were detected in participants with febrile illness. Exposures to C. burnetii and to SFG Rickettsia were highly prevalent, and interactions with livestock were associated with increased odds of illness with both pathogens. Further characterisation of the burden and risks for these diseases is warranted.


  • Open Access

    Host-response transcriptional biomarkers accurately discriminate bacterial and viral infections of global relevance

    by Emily R. Ko, Megan E. Reller, L. Gayani Tillekeratne, Champica K. Bodinayake, Cameron Miller, Thomas W. Burke, Ricardo Henao, Micah T. McClain, Sunil Suchindran, Bradly Nicholson, et al.

    Diagnostic limitations challenge management of clinically indistinguishable acute infectious illness globally. Gene expression classification models show great promise distinguishing causes of fever. We generated transcriptional data for a 294-participant (USA, Sri Lanka) discovery cohort with adjudicated viral or bacterial infections of diverse etiology or non-infectious disease mimics. We then derived and cross-validated gene expression classifiers including: 1) a single model to distinguish bacterial vs. viral (Global Fever-Bacterial/Viral [GF-B/V]) and 2) a two-model system to discriminate bacterial and viral in the context of noninfection (Global Fever-Bacterial/Viral/Non-infectious [GF-B/V/N]). We then translated to a multiplex RT-PCR assay and independent validation involved 101 participants (USA, Sri Lanka, Australia, Cambodia, Tanzania). The GF-B/V model discriminated bacterial from viral infection in the discovery cohort an area under the receiver operator curve (AUROC) of 0.93. Validation in an independent cohort demonstrated the GF-B/V model had an AUROC of 0.84 (95% CI 0.76–0.90) with overall accuracy of 81.6% (95% CI 72.7–88.5). Performance did not vary with age, demographics, or site. Host transcriptional response diagnostics distinguish bacterial and viral illness across global sites with diverse endemic pathogens.


  • Open Access

    Antibacterial Utilization for Febrile Illnesses and Laboratory-Confirmed Bloodstream Infections in Northern Tanzania

    by Ganga S Moorthy, Deng B Madut, Kajiru G Kilonzo, Bingileki F Lwezaula, Ronald Mbwasi, Blandina T Mmbaga, James S Ngocho, Wilbrod Saganda, John P Bonnewell, Manuela Carugati, et al.

    We describe antibacterial use in light of microbiology data and treatment guidelines for common febrile syndromes in Moshi, Tanzania. We compared data from 2 hospital-based prospective cohort studies, cohort 1 (2011–2014) and cohort 2 (2016–2019), that enrolled febrile children and adults. A study team member administered a standardized questionnaire, performed a physical examination, and collected blood cultures. Participants with bloodstream infection (BSI) were categorized as receiving effective or ineffective therapy based upon antimicrobial susceptibility interpretations. Antibacterials prescribed for treatment of pneumonia, urinary tract infection (UTI), or presumed sepsis were compared with World Health Organization and Tanzania Standard Treatment Guidelines. We used descriptive statistics and logistic regression to describe antibacterial use. Among participants, 430 of 1043 (41.2%) and 501 of 1132 (44.3%) reported antibacterial use prior to admission in cohorts 1 and 2, respectively. During admission, 930 of 1043 (89.2%) received antibacterials in cohort 1 and 1060 of 1132 (93.6%) in cohort 2. Inpatient use of ceftriaxone, metronidazole, and ampicillin increased between cohorts (P ≤ .002 for each). BSI was detected in 38 (3.6%) participants in cohort 1 and 47 (4.2%) in cohort 2. Of 85 participants with BSI, 81 (95.3%) had complete data and 52 (64.2%) were prescribed effective antibacterials. Guideline-consistent therapy in cohort 1 and cohort 2 was as follows: pneumonia, 87.4% and 56.8%; UTI, 87.6% and 69.0%; sepsis, 84.4% and 61.2% (P ≤ .001 for each). Receipt of antibacterials for febrile illness was common. While guideline-consistent prescribing increased over time, more than one-third of participants with BSI received ineffective antibacterials.